The goal of this clinical study is to learn whether a custom-made porous zirconia shell can support good-quality new bone when widening the lower back jaw before dental implant placement. The study includes adults whose jawbone in this area is too narrow for implants (Seibert Class I defects). The main question it aims to answer is: What is the quality of the new bone formed under a porous zirconia shell, and how much inflammation does the tissue show? Participants will: * Receive gum treatment and a CBCT scan before surgery * Have bone augmentation surgery, in which a digitally designed porous zirconia shell is fixed over a mixture of their own bone and bovine bone graft * Return after 2 weeks for suture removal and a check of the wound * Return after 6 months for a CBCT scan, removal of the shell, collection of a small bone sample (biopsy), and dental implant placement
Horizontal bone loss in the posterior mandible often prevents dental implant placement. The Khoury technique uses thin autogenous cortical bone plates to rebuild the ridge, but harvesting these plates causes donor-site morbidity, is technically demanding, and is limited by available bone. Zirconia is biocompatible, mechanically strong and osteoconductive, and has shown low inflammatory response. However, it has not been studied as a shell replacing autogenous bone plates. In this single-arm study, 10 adults with Seibert Class I defects in the posterior mandible will first receive non-surgical periodontal therapy. Compliance will be checked after 1 month. A zirconia shell with 1.5 mm pores will be digitally designed from each patient's CBCT scan, milled on a 5-axis machine, then cleaned and sterilized. Under local anesthesia, buccal and lingual full-thickness flaps will be raised and the recipient bone decorticated. Autogenous bone chips will be harvested from the mandibular body with a bone chip maker and mixed 1:1 with xenograft. The shell will be fixed over the graft with 3-4 buccal screws. The flaps will be advanced and closed with a double-layer suture. After 6 months, the shell will be removed, a core biopsy will be taken, and an implant will be placed. The biopsies will be fixed in 10% formalin and analyzed histologically, histomorphometrically and for tissue inflammatory response.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
A CAD/CAM-milled zirconia shell with 1.5 mm pores, designed from each patient's CBCT scan and fixed with 3-4 buccal screws over a 1:1 mix of autogenous bone chips and xenograft. It replaces the autogenous cortical plates used in the Khoury technique and is removed after 6 months.
October University for Modern Sciences and Arts (MSA), Faculty of Dentistry
Giza, Giza Governorate, Egypt
RECRUITINGQuality of Newly Formed Bone Assessed by Descriptive Histological Analysis of the Core Biopsy
Qualitative histological assessment of the core bone biopsy harvested from the augmented site. Biopsies will be fixed in 10% formalin, processed and examined under light microscopy. The tissue structure of the augmented site will be described (Dellavia et al., 2021). Results will be reported as the number of participants whose biopsy shows newly formed bone in continuity with the native bone.
Time frame: 6 months after ridge augmentation (at shell removal and implant placement)
Percentage of newly formed bone
Histomorphometric measurement of the new bone area as a percentage of the total biopsy area.
Time frame: 6 months after augmentation
Percentage of residual graft material
Histomorphometric measurement of the remaining graft particle area as a percentage of the total biopsy area.
Time frame: 6 months after augmentation
Percentage of soft tissue
Histomorphometric measurement of the non-mineralized connective tissue area as a percentage of the total biopsy area.
Time frame: 6 months after augmentation
Inflammatory cell infiltration score
Semi-quantitative tissue response score from 0 (no inflammatory cells) to 4 (severe cellular infiltrate or tissue necrosis), based on the presence of lymphocytes, macrophages, foreign body giant cells, eosinophils and neutrophils.
Time frame: 6 months after augmentation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.